The table below shows Cytek Biosciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$201.49M
$200.45M
$193.01M
$2.96M
$2.18M
$710.00K
Cost of revenue
$97.03M
$89.35M
$83.59M
$63.06M
$48.81M
$41.13M
Gross profit
$104.46M
$111.11M
$109.43M
$100.97M
$79.14M
$51.71M
R&D
$36.47M
$39.40M
$44.15M
$34.86M
$24.44M
$13.69M
CTKB annual revenue (10-K history)
Cytek Biosciences, Inc. reported annual revenue of $201.49M for fiscal year 2025. That is up 0.5% from $200.45M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $710.00K (FY 2020) to $201.49M. Figures come from the company's audited annual reports as filed with the SEC.